{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:26:46Z","timestamp":1791397606893,"version":"4.3.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00428-020-02937-y","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T21:02:48Z","timestamp":1601758968000},"page":"779-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["ALK-positive histiocytosis associated with chronic lymphocytic leukaemia\/small lymphocytic lymphoma: a multitarget response under ibrutinib"],"prefix":"10.1007","volume":"478","author":[{"given":"Charlotte","family":"Syrykh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Ysebaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"P\u00e9ricart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne M.","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Meggetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Kanoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-7512","authenticated-orcid":false,"given":"Camille","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,3]]},"reference":[{"key":"2937_CR1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"J-F Emile","year":"2016","unstructured":"Emile J-F, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM, Histiocyte Society (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127:2672\u20132681. https:\/\/doi.org\/10.1182\/blood-2016-01-690636","journal-title":"Blood"},{"key":"2937_CR2","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","volume":"112","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Lamant L, Algar E, Delsol G, Tsang WYW, Lee KC, Tiedemann K, Chow CW (2008) ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood 112:2965\u20132968. https:\/\/doi.org\/10.1182\/blood-2008-03-147017","journal-title":"Blood"},{"key":"2937_CR3","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.3324\/haematol.2019.230094","volume":"104","author":"GK Gupta","year":"2019","unstructured":"Gupta GK, Xi L, Pack SD, Jones JB, Pittaluga S, Raffeld M, Jaffe ES (2019) ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female. Haematologica 104:e534\u2013e536. https:\/\/doi.org\/10.3324\/haematol.2019.230094","journal-title":"Haematologica"},{"key":"2937_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1093526617740784","volume":"21","author":"H Huang","year":"2018","unstructured":"Huang H, Gheorghe G, North PE, Suchi M (2018) Expanding the phenotype of ALK-positive histiocytosis: a report of 2 cases. Pediatr Dev Pathol 21:449\u2013455. https:\/\/doi.org\/10.1177\/1093526617740784","journal-title":"Pediatr Dev Pathol"},{"key":"2937_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","volume":"32","author":"KTE Chang","year":"2019","unstructured":"Chang KTE, Tay AZE, Kuick CH, Chen H, Algar E, Taubenheim N, Campbell J, Mechinaud F, Campbell M, Super L, Chantranuwat C, Yuen ST, Chan JKC, Chow CW (2019) ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Mod Pathol 32:598\u2013608. https:\/\/doi.org\/10.1038\/s41379-018-0168-6","journal-title":"Mod Pathol"},{"key":"2937_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","volume":"6","author":"EL Diamond","year":"2016","unstructured":"Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, Wang Z, Choi J, Kim E, Cohen-Aubart F, Lee SCW, Gao Y, Micol JB, Campbell P, Walsh MP, Sylvester B, Dolgalev I, Aminova O, Heguy A, Zappile P, Nakitandwe J, Ganzel C, Dalton JD, Ellison DW, Estrada-Veras J, Lacouture M, Gahl WA, Stephens PJ, Miller VA, Ross JS, Ali SM, Briggs SR, Fasan O, Block J, Heritier S, Donadieu J, Solit DB, Hyman DM, Baselga J, Janku F, Taylor BS, Park CY, Amoura Z, Dogan A, Emile JF, Rosen N, Gruber TA, Abdel-Wahab O (2016) Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 6:154\u2013165. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0913","journal-title":"Cancer Discov"},{"key":"2937_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","volume":"1","author":"JI Estrada-Veras","year":"2017","unstructured":"Estrada-Veras JI, O\u2019Brien KJ, Boyd LC, Dave RH, Durham BH, Xi L, Malayeri AA, Chen MY, Gardner PJ, Alvarado Enriquez JR, Shah N, Abdel-Wahab O, Gochuico BR, Raffeld M, Jaffe ES, Gahl WA (2017) The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv 1:357\u2013366. https:\/\/doi.org\/10.1182\/bloodadvances.2016001784","journal-title":"Blood Adv"},{"key":"2937_CR8","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/PAS.0b013e318283099f","volume":"37","author":"DS West","year":"2013","unstructured":"West DS, Dogan A, Quint PS, Tricker-Klar ML, Porcher JC, Ketterling RP, Law ME, McPhail ED, Viswanatha DS, Kurtin PJ, Dao LN, Ritzer RD, Nowakowski GS, Feldman AL (2013) Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation. Am J Surg Pathol 37:978\u2013986. https:\/\/doi.org\/10.1097\/PAS.0b013e318283099f","journal-title":"Am J Surg Pathol"},{"key":"2937_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00428-019-02691-w","volume":"476","author":"S P\u00e9ricart","year":"2019","unstructured":"P\u00e9ricart S, Waysse C, Siegfried A, Struski S, Delabesse E, Laurent C, Evrard S (2019) Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. Virchows Arch 476:609\u2013614. https:\/\/doi.org\/10.1007\/s00428-019-02691-w","journal-title":"Virchows Arch"},{"key":"2937_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","volume":"24","author":"H Shao","year":"2011","unstructured":"Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES (2011) Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases. Mod Pathol 24:1421\u20131432. https:\/\/doi.org\/10.1038\/modpathol.2011.102","journal-title":"Mod Pathol"},{"key":"2937_CR11","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1038\/s41388-018-0397-7","volume":"37","author":"T Li","year":"2018","unstructured":"Li T, Deng Y, Shi Y, Tian R, Chen Y, Zou L, Kazi JU, R\u00f6nnstrand L, Feng B, Chan SO, Chan WY, Sun J, Zhao H (2018) Bruton\u2019s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma. Oncogene 37:6180\u20136194. https:\/\/doi.org\/10.1038\/s41388-018-0397-7","journal-title":"Oncogene"},{"key":"2937_CR12","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1038\/bcj.2015.74","volume":"5","author":"F Boissard","year":"2015","unstructured":"Boissard F, Fourni\u00e9 J-J, Quillet-Mary A, Ysebaert L, Poupot M (2015) Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients. Blood Cancer J 5:e355. https:\/\/doi.org\/10.1038\/bcj.2015.74","journal-title":"Blood Cancer J"},{"key":"2937_CR13","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","volume":"117","author":"SEM Herman","year":"2011","unstructured":"Herman SEM, Gordon AL, Hertlein E, Ramanunni A, Zhang X, Jaglowski S, Flynn J, Jones J, Blum KA, Buggy JJ, Hamdy A, Johnson AJ, Byrd JC (2011) Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765. Blood 117:6287\u20136296. https:\/\/doi.org\/10.1182\/blood-2011-01-328484","journal-title":"Blood"},{"key":"2937_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1182\/blood-2011-10-386417","volume":"119","author":"S Ponader","year":"2012","unstructured":"Ponader S, Chen S-S, Buggy JJ, Balakrishnan K, Gandhi V, Wierda WG, Keating MJ, O'Brien S, Chiorazzi N, Burger JA (2012) The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood 119:1182\u20131189. https:\/\/doi.org\/10.1182\/blood-2011-10-386417","journal-title":"Blood"},{"key":"2937_CR15","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1634\/theoncologist.2016-0488","volume":"22","author":"JS Ross","year":"2017","unstructured":"Ross JS, Ali SM, Fasan O, Block J, Pal S, Elvin JA, Schrock AB, Suh J, Nozad S, Kim S, Jeong Lee H, Sheehan CE, Jones DM, Vergilio JA, Ramkissoon S, Severson E, Daniel S, Fabrizio D, Frampton G, Miller VA, Stephens PJ, Gay LM (2017) ALK fusions in a wide variety of tumor types respond to anti-ALK targeted therapy. Oncologist 22:1444\u20131450. https:\/\/doi.org\/10.1634\/theoncologist.2016-0488","journal-title":"Oncologist"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-020-02937-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T20:38:09Z","timestamp":1633379889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-020-02937-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,3]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02937-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,3]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Tissue samples were collected at the <i>CRB Cancer des H\u00f4pitaux de Toulouse<\/i> bio bank. According to French law, the collection has been declared to the Ministry of Higher Education and Research (DC 2009-989) and obtained a transfer agreement (DC-2008-820). The samples were processed following standard ethical procedures (Helsinki Declaration), and the study was approved by the local ethical committee <i>Comit\u00e9 de Protection des Personnes Sud-Ouest et Outremer II<\/i>. Clinical and biological samples annotations have been declared to the CNIL (<i>Comit\u00e9 National Informatique et Libert\u00e9<\/i>; i.e. Data Processing and Liberties National Committee).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed patient consent to participate has been obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed patient consent for publication has been obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}